The much-talked-about Retatrutide 20mg pen , a novel dual GIP and GLP-1 target , is currently being assessed by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK. Widespread availability https://dirstop.com/story29623689/retatrutide-20mg-pen-uk-launch-news